Order Book analysis by شرکت سبدگردان فارابی about Stock جهش: Buy recommendation (3/5/2025)

Farabi's portfolio company purchased 0.603 million shares of mutation on 14/12/15 and currently accounts for 1.586 % of the mutation shares in its joint portfolio.